Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2779013171', 'doi': 'https://doi.org/10.1089/cbr.2017.2216', 'title': 'Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines', 'display_name': 'Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines', 'publication_year': 2017, 'publication_date': '2017-09-01', 'ids': {'openalex': 'https://openalex.org/W2779013171', 'doi': 'https://doi.org/10.1089/cbr.2017.2216', 'mag': '2779013171', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/28910149'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/cbr.2017.2216', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S87235987', 'display_name': 'Cancer Biotherapy and Radiopharmaceuticals', 'issn_l': '1084-9785', 'issn': ['1084-9785', '1557-8852'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5072530643', 'display_name': 'Ines De Pauw', 'orcid': 'https://orcid.org/0000-0003-2967-9611'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': True, 'raw_author_name': 'Ines De Pauw', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033135247', 'display_name': 'An Wouters', 'orcid': 'https://orcid.org/0000-0001-7771-1239'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'An Wouters', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091861573', 'display_name': 'Jolien Van den Bossche', 'orcid': 'https://orcid.org/0000-0002-2993-024X'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Jolien Van den Bossche', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046892369', 'display_name': 'Vanessa Deschoolmeester', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}, {'id': 'https://openalex.org/I4210102047', 'display_name': 'Antwerp University Hospital', 'ror': 'https://ror.org/01hwamj44', 'country_code': 'BE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210102047']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Vanessa Deschoolmeester', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}, {'raw_affiliation_string': 'Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I4210102047']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000168863', 'display_name': 'Hasan Baysal', 'orcid': 'https://orcid.org/0000-0002-5048-9778'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Hasan Baysal', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056727791', 'display_name': 'Patrick Pauwels', 'orcid': 'https://orcid.org/0000-0002-8553-1921'}, 'institutions': [{'id': 'https://openalex.org/I4210102047', 'display_name': 'Antwerp University Hospital', 'ror': 'https://ror.org/01hwamj44', 'country_code': 'BE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210102047']}, {'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Patrick Pauwels', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I4210102047']}, {'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024390084', 'display_name': 'Marc Peeters', 'orcid': 'https://orcid.org/0000-0003-4969-2303'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}, {'id': 'https://openalex.org/I4210102047', 'display_name': 'Antwerp University Hospital', 'ror': 'https://ror.org/01hwamj44', 'country_code': 'BE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210102047']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Marc Peeters', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}, {'raw_affiliation_string': 'Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I4210102047']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007067879', 'display_name': 'Jan B. Vermorken', 'orcid': 'https://orcid.org/0000-0001-8515-7848'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}, {'id': 'https://openalex.org/I4210102047', 'display_name': 'Antwerp University Hospital', 'ror': 'https://ror.org/01hwamj44', 'country_code': 'BE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210102047']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Jan B. Vermorken', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}, {'raw_affiliation_string': 'Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I4210102047']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5007235093', 'display_name': 'Filip Lardon', 'orcid': 'https://orcid.org/0000-0001-7174-4144'}, 'institutions': [{'id': 'https://openalex.org/I149213910', 'display_name': 'University of Antwerp', 'ror': 'https://ror.org/008x57b05', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I149213910']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Filip Lardon', 'raw_affiliation_strings': ['Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.', 'institution_ids': ['https://openalex.org/I149213910']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5072530643'], 'corresponding_institution_ids': ['https://openalex.org/I149213910'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.941, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 17, 'citation_normalized_percentile': {'value': 0.873198, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '32', 'issue': '7', 'first_page': '229', 'last_page': '238'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2 Signaling in Breast Cancer Treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2 Signaling in Breast Cancer Treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Therapeutic Antibodies: Development, Engineering, and Applications', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10602', 'display_name': 'Glycosylation in Health and Disease', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/egfr-inhibitors', 'display_name': 'EGFR inhibitors', 'score': 0.5813969}, {'id': 'https://openalex.org/keywords/egfr', 'display_name': 'EGFR', 'score': 0.557943}], 'concepts': [{'id': 'https://openalex.org/C2779998722', 'wikidata': 'https://www.wikidata.org/wiki/Q420296', 'display_name': 'Cetuximab', 'level': 4, 'score': 0.99013233}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.8117642}, {'id': 'https://openalex.org/C2776833033', 'wikidata': 'https://www.wikidata.org/wiki/Q1783924', 'display_name': 'Head and neck squamous-cell carcinoma', 'level': 4, 'score': 0.7230139}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.64755034}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.62821007}, {'id': 'https://openalex.org/C2777506169', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'EGFR inhibitors', 'level': 4, 'score': 0.5813969}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5542964}, {'id': 'https://openalex.org/C555283112', 'wikidata': 'https://www.wikidata.org/wiki/Q1637543', 'display_name': 'Carcinogenesis', 'level': 3, 'score': 0.47932184}, {'id': 'https://openalex.org/C2776362946', 'wikidata': 'https://www.wikidata.org/wiki/Q424374', 'display_name': 'Epidermal growth factor', 'level': 3, 'score': 0.437662}, {'id': 'https://openalex.org/C2776530083', 'wikidata': 'https://www.wikidata.org/wiki/Q1783924', 'display_name': 'Head and neck cancer', 'level': 3, 'score': 0.42580926}, {'id': 'https://openalex.org/C26375932', 'wikidata': 'https://www.wikidata.org/wiki/Q118226', 'display_name': 'Growth factor receptor', 'level': 3, 'score': 0.41274974}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.39846748}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3407988}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32594222}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.27130938}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.15914792}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.101747364}], 'mesh': [{'descriptor_ui': 'D002294', 'descriptor_name': 'Carcinoma, Squamous Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000068818', 'descriptor_name': 'Cetuximab', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D002945', 'descriptor_name': 'Cisplatin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D006258', 'descriptor_name': 'Head and Neck Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D020893', 'descriptor_name': 'Receptor, ErbB-3', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D002294', 'descriptor_name': 'Carcinoma, Squamous Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002294', 'descriptor_name': 'Carcinoma, Squamous Cell', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068818', 'descriptor_name': 'Cetuximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002945', 'descriptor_name': 'Cisplatin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006258', 'descriptor_name': 'Head and Neck Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006258', 'descriptor_name': 'Head and Neck Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020893', 'descriptor_name': 'Receptor, ErbB-3', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077195', 'descriptor_name': 'Squamous Cell Carcinoma of Head and Neck', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/cbr.2017.2216', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S87235987', 'display_name': 'Cancer Biotherapy and Radiopharmaceuticals', 'issn_l': '1084-9785', 'issn': ['1084-9785', '1557-8852'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/28910149', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.85, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 36, 'referenced_works': ['https://openalex.org/W1505370951', 'https://openalex.org/W1548944336', 'https://openalex.org/W1901167328', 'https://openalex.org/W1961186603', 'https://openalex.org/W1964414938', 'https://openalex.org/W1974024530', 'https://openalex.org/W1990956554', 'https://openalex.org/W2004439203', 'https://openalex.org/W2017081079', 'https://openalex.org/W2019443090', 'https://openalex.org/W2030579093', 'https://openalex.org/W2049112891', 'https://openalex.org/W2051867845', 'https://openalex.org/W2057458801', 'https://openalex.org/W2071289226', 'https://openalex.org/W2082969979', 'https://openalex.org/W2085690948', 'https://openalex.org/W2096869304', 'https://openalex.org/W2112845420', 'https://openalex.org/W2113672655', 'https://openalex.org/W2124462445', 'https://openalex.org/W2146086021', 'https://openalex.org/W2151730005', 'https://openalex.org/W2156382128', 'https://openalex.org/W2157624835', 'https://openalex.org/W2157824687', 'https://openalex.org/W2158819778', 'https://openalex.org/W2159955722', 'https://openalex.org/W2168730865', 'https://openalex.org/W2169249953', 'https://openalex.org/W2211884070', 'https://openalex.org/W2295644844', 'https://openalex.org/W2460643788', 'https://openalex.org/W2512970891', 'https://openalex.org/W2529025271', 'https://openalex.org/W2542944545'], 'related_works': ['https://openalex.org/W4362476735', 'https://openalex.org/W337839523', 'https://openalex.org/W3201171647', 'https://openalex.org/W2810203835', 'https://openalex.org/W2496065307', 'https://openalex.org/W2145309828', 'https://openalex.org/W2096869304', 'https://openalex.org/W2081221684', 'https://openalex.org/W1506139159', 'https://openalex.org/W1505370951'], 'abstract_inverted_index': {'Aberrant': [0], 'signaling': [1], 'of': [2, 16, 38, 46, 179], 'the': [3, 14, 44, 147, 177, 185], 'epidermal': [4], 'growth': [5], 'factor': [6], 'receptor': [7], '(EGFR)': [8], 'plays': [9], 'a': [10, 30, 66, 80, 92], 'crucial': [11], 'role': [12], 'in': [13, 79, 96, 102], 'tumorigenesis': [15], 'many': [17], 'cancer': [18], 'types,': [19], 'including': [20], 'head': [21], 'and': [22, 51, 95, 104, 111, 126, 139], 'neck': [23], 'squamous': [24], 'cell': [25, 107, 123], 'carcinoma': [26], '(HNSCC),': [27], 'making': [28], 'it': [29], 'compelling': [31], 'drug': [32], 'target.': [33], 'After': [34], 'initial': [35], 'promising': [36], 'results': [37, 116], 'EGFR-targeted': [39], 'therapies': [40], 'such': [41], 'as': [42, 91], 'cetuximab,': [43], 'problem': [45], 'therapeutic': [47, 83, 181], 'resistance': [48, 162], 'is': [49, 65, 157], 'emerging': [50], 'new': [52, 180], 'treatment': [53, 74, 166], 'options': [54], 'are': [55], 'necessary.': [56], 'In': [57, 85, 143], 'contrast': [58], 'to': [59, 89, 120, 149, 159, 164, 176, 183, 187], 'first-generation': [60], 'EGFR': [61, 188], 'inhibitors,': [62], 'MEHD7945A': [63, 76, 90, 121, 138, 145], '(duligotuzumab)': [64], 'monoclonal': [67], 'antibody': [68], 'with': [69, 75, 98], 'dual': [70], 'EGFR/HER3': [71], 'specificity.': [72], 'Consequently,': [73], 'may': [77], 'result': [78], 'more': [81], 'pronounced': [82], 'benefit.': [84], 'this': [86], 'study,': [87], 'sensitivity': [88, 119], 'single': [93], 'agent': [94], 'combination': [97], 'cisplatin': [99, 140], 'was': [100, 122, 141], 'investigated': [101], 'cetuximab-sensitive': [103], '-resistant': [105], 'HNSCC': [106], 'lines': [108], 'under': [109], 'normal': [110], 'reduced': [112], 'oxygen': [113, 129], 'conditions.': [114], 'The': [115], 'demonstrated': [117], 'that': [118], 'line': [124], 'dependent': [125], 'influenced': [127], 'by': [128], 'concentration.': [130], 'An': [131], 'additive,': [132], 'but': [133], 'not': [134], 'synergistic,': [135], 'interaction': [136], 'between': [137], 'observed.': [142], 'conclusion,': [144], 'has': [146], 'potential': [148], 'partially': [150], 'overcome': [151], 'cetuximab': [152, 165], 'resistance.': [153], 'Nevertheless,': [154], 'further': [155], 'research': [156], 'warranted': [158], 'determine': [160], 'additional': [161], 'mechanisms': [163, 172], 'besides': [167], 'HER3': [168], 'signaling.': [169], 'Unraveling': [170], 'these': [171], 'will': [173], 'ultimately': [174], 'lead': [175], 'development': [178], 'strategies': [182], 'improve': [184], 'response': [186], 'blockage.': [189]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2779013171', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 6}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 3}], 'updated_date': '2024-09-10T08:59:19.257258', 'created_date': '2018-01-05'}